|
|
|
시장보고서
US Markets for Ventricular Assist Devices 2008
|
Abstract
This market was valued at almost $150 million in 2007 with revenues generated
by the bridge-to-transplant segment representing approximately half of the
total market.
The US ventricular assist device market comprises commercially available
paracorporeal and implantable devices used in bridge-to-recovery,
bridge-to-transplant, and destination therapy heart failure patients.
Research Methodology
The following report uses a number of methodologies to gather and present data
and analysis. At the outset, a large survey of secondary sources is conducted
. These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include:
- Government Sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Center for Health Statistics data
- Ventricular Assist Device(VAD) Companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal Databases and Reports
- Previous reports on similar/related sources
- General Internet Searches, Medical Literature, and Newspaper/Magazine
Searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research.
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is, thus, either discarded or marked as high or low priority. It
is then organized appropriately as determined by the structure and sectioning
of the report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various VAD market segments. These
assumptions are then used to determine hypotheses using both inductive and
deductive approaches. On the quantitative front, these hypotheses result in
full historical and projected market data sets (market sizes [units and US$]
and market shares).
Step 3: At this stage, the research is in position for its most
important primary interviews. Throughout the secondary research, industry and
medical experts are identified . These experts are now contacted by telephone
and asked to participate in interviews on recent trends and developments in
the industry.
Interviews are either conducted at the time of the initial call or scheduled
at the convenience of the expert. Interview questions are tailored to the
expertise of the particular interviewee, although in most cases, the most
important questions are asked of all experts. The questions are largely based
on the assumptions and hypotheses developed in Step2, which are then either
augmented , discarded , or adjusted, based on the views and positions put
forth. Attempts are made, whenever possible, to cross check the views of
various experts against each other and reach positions of consensus on issues
and market numbers.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group . All research results are
assessed and cross checked thoroughly to determine their validity, relevance,
and weight. From this process, qualitative conclusions are reached and data
points finalized . Forecast Methodology
In addition to Steps 1 through 4 (as outlined above), the following
methodology was followed in developing forecast assumptions for this report. A
comprehensive break down of various VAD procedures was prepared using data
from several sources including professional associations, government
statistics, and private research/media sources. Industry experts and
practitioners were consulted to ensure accuracy and verify observed trends. As
a cross check , total industry revenues available through 10Ks and other
sources were compared against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and in house experts, year by year growth rates and
average selling prices were applied individually to each subcategory to derive
forecasts. These estimates were cross checked by industry experts (marketing
managers, product managers, CEOs, etc.) and further refined .
Overall findings were compared against market and procedure forecasts
published by other sources to ensure reasonable estimates.
Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 US VENTRICULAR ASSIST DEVICE MARKET
- 1.1 Market Overview
- 1.1.1 Heart Failure
- 1.1.1.1 Heart Failure Treatment Options
- 1.1.1.2 Heart Failure Treatment Patient Indications
- 1.2 Market Analysis
- 1.2.1 Ventricular Assist Device Clinical Trials
- 1.2.1.1 Clinical Trial Summaries
- 1.2.1.2 Clinical Trial Status and Assumptions
- 1.2.2 Procedures
- 1.2.3 Market Forecast
- 1.2.4 Market Drivers and Limiters
- 1.2.4.1 Market Drivers
- 1.2.4.2 Market Limiters
- 1.3 Competitive Analysis
2.0 BRIDGE-TO-RECOVERY MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Procedures
- 2.2.2 Market Forecast
- 2.2.3 Market Drivers and Limiters
- 2.3 Competitive Analysis
3.0 BRIDGE-TO-TRANSPLANT MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.2 Market Forecast
- 3.2.3 Market Drivers and Limiters
- 3.3 Competitive Analysis
4.0 DESTINATION THERAPY MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.2 Market Forecast
- 4.2.3 Market Drivers and Limiters
- 4.3 Competitive Analysis
APPENDIX A: MRG ACRONYMS AND INITIALISMS
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: VAD Market, by Segment, as a % of Total, US, 2007 and 2012
- Exhibit 2: BTR Unit Model, US, 2006 - 2012
- Exhibit 3: BTT Market Growth, US, 2007 - 2012
- Exhibit 4: DT Penetration Rate, US, 2006 - 2012
- Exhibit 5: Leading and Emerging Competitors in the VAD Market, US, 2007
METHODOLOGY
CHAPTER 1: US VENTRICULAR ASSIST DEVICE MARKET
- Exhibit 6: VAD Market, US (US$), 2006 - 2012
- Exhibit 7: Commercial VAD Availability, US, 2007
- Exhibit 8: Precommercial VADs in Clinical Development, US
- Exhibit 9: HeartMate II BTT Clinical Trial Summary, 2007
- Exhibit 10: HeartMate II DT Clinical Trial Summary, 2007
- Exhibit 11: VentrAssist BTT Clinical Trial Summary, 2007
- Exhibit 12: VentrAssist DT Clinical Trial Summary, 2007
- Exhibit 13: Other VAD Clinical Trial Updates, 2007
- Exhibit 14: Precommercial VAD Clinical Trial Status and Approval
Assumptions, US, 2007
- Exhibit 15: VAD Approval Timeline Assumptions, US, 2006 - 2012
- Exhibit 16: VAD Procedures, by Indication, US, 2006 - 2012 (Graphical
Format)
- Exhibit 17: VAD Procedures, by Indication, as a % of Total, US, 2006 -
2012
- Exhibit 18: VAD Procedures, by Indication, US, 2006 - 2012 (Tabular
Format)
- Exhibit 19: CMS VAD-Related Reimbursement Codes and Rates, 2007
- Exhibit 20: VAD Unit Model, US, 2006 - 2012
- Exhibit 21: VAD Unit Model, by Segment, US, 2006 - 2012
- Exhibit 22: VAD Market, by Segment, US (US$), 2006 - 2012 (Graphical
Format)
- Exhibit 23: VAD Market, by Segment, US (US$), 2006 - 2012 (Tabular Format)
- Exhibit 24: VAD Market Growth, by Segment, US, 2007 - 2012 (Graphical
Format)
- Exhibit 25: VAD Market Growth, by Segment, US, 2007 - 2012 (Tabular
Format)
- Exhibit 26: VAD Market, by Segment, as a % of Total, US, 2007 and 2012
- Exhibit 27: VAD Market, by Segment, as a % of Total, US, 2006 - 2012
- Exhibit 28: Drivers and Limiters of the VAD Market, US
- Exhibit 29: Leading Competitors in the VAD Market, as a % of Total, US,
2007 (Graphical Format)
- Exhibit 30: Leading Competitors in the VAD Market, as a % of Total, US,
2007 (Tabular Format)
CHAPTER 2: BRIDGE-TO-RECOVERY MARKET
- Exhibit 31: BTR Market, US (US$), 2006 - 2012 (Graphical Format)
- Exhibit 32: BTR Procedures, by Patient Type, as a % of Total, US, 2006 -
2012
- Exhibit 33: BTR Procedure Growth, by Patient Type, US, 2007 - 2012
- Exhibit 34: BTR Procedures, by Patient Type, US, 2006 - 2012
- Exhibit 35: Potential BTR Patient Population and VAD Adoption Model, by
Patient Type, US, 2006 - 2012
- Exhibit 36: BTR Procedures, Potential Patient Population, and VAD Adoption
Model, by Patient Type, US, 2006 - 2012
- Exhibit 37: BTR Procedure and Potential Patient Population Growth, by
Patient Type, US, 2007 - 2012
- Exhibit 38: BTR Market Growth, US, 2007 - 2012
- Exhibit 39: BTR VAD Unit Model, US, 2006 - 2012 (Graphical Format)
- Exhibit 40: BTR VAD Unit Model, US, 2006 - 2012 (Tabular Format)
- Exhibit 41: BTR Market, US (US$), 2006 - 2012 (Tabular Format)
- Exhibit 42: Drivers of the BTR Market, US
- Exhibit 43: Limiters of the BTR Market, US
- Exhibit 44: Leading Competitors in the BTR Market, as a % of Total, US,
2007 (Graphical Format)
- Exhibit 45: Leading Competitors in the BTR Market, as a % of Total, US,
2007 (Tabular Format)
CHAPTER 3: BRIDGE-TO-TRANSPLANT MARKET
- Exhibit 46: BTT Market, US (US$), 2006 - 2012 (Graphical Format)
- Exhibit 47: BTT Procedures, US, 2006 - 2012
- Exhibit 48: BTT Procedures, Potential Patient Population, and VAD Adoption
Model, US, 2006 - 2012
- Exhibit 49: BTT VAD Unit Model, US, 2006 - 2012 (Graphical Format)
- Exhibit 50: BTT Market Growth, US, 2007 - 2012
- Exhibit 51: BTT VAD Unit Model, US, 2006 - 2012 (Tabular Format)
- Exhibit 52: BTT Market, US (US$), 2006 - 2012 (Tabular Format)
- Exhibit 53: Drivers of the BTT Market, US
- Exhibit 54: Limiters of the BTT Market, US
- Exhibit 55: Leading Competitors in the BTT Market, as a % of Total, US,
(Graphical Format)
- Exhibit 56: Leading Competitors in the BTT Market, as a % of Total, US,
(Tabular Format)
CHAPTER 4: DESTINATION THERAPY MARKET
- Exhibit 57: DT Market, US (US$), 2006 - 2012 (Graphical Format)
- Exhibit 58: DT Procedures and Penetration Rate, US, 2006 - 2012
- Exhibit 59: DT Procedures and Patient Population Growth, US, 2007 - 2012
- Exhibit 60: DT Procedures, Potential Patient Population, and VAD Adoption
Model, US, 2006 - 2012
- Exhibit 61: DT Market Growth, US, 2007 - 2012
- Exhibit 62: DT VAD Unit Model, US, 2006 - 2012
- Exhibit 63: DT Market, US (US$), 2006 - 2012 (Tabular Format)
- Exhibit 64: Drivers of the DT Market, US
- Exhibit 65: Limiters of the DT Market, US
APPENDIX A: MRG ACRONYMS AND INITIALISMS
|
 |
